NeuroMetrix, Inc. (NURO)
USD 4.47
(1.08%)
USD 4.47
(1.08%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -6.52 Million USD | -49.51% |
| 2022 | -4.36 Million USD | -98.05% |
| 2021 | -2.2 Million USD | -10.13% |
| 2020 | -2 Million USD | 45.13% |
| 2019 | -3.64 Million USD | -15558.6% |
| 2018 | 23.6 Thousand USD | 100.18% |
| 2017 | -12.85 Million USD | 13.77% |
| 2016 | -14.91 Million USD | -62.32% |
| 2015 | -9.18 Million USD | -18.3% |
| 2014 | -7.76 Million USD | 3.15% |
| 2013 | -8.01 Million USD | 19.87% |
| 2012 | -10 Million USD | -0.26% |
| 2011 | -9.98 Million USD | 40.91% |
| 2010 | -16.89 Million USD | -41.73% |
| 2009 | -11.91 Million USD | 57.02% |
| 2008 | -27.73 Million USD | -230.97% |
| 2007 | -8.37 Million USD | -296.32% |
| 2006 | 4.26 Million USD | 354.86% |
| 2005 | 938.25 Thousand USD | 121.9% |
| 2004 | -4.28 Million USD | -16.83% |
| 2003 | -3.66 Million USD | 23.51% |
| 2002 | -4.79 Million USD | 45.01% |
| 2001 | -8.71 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -1.48 Million USD | 50.89% |
| 2024 Q3 | -1.5 Million USD | -1.36% |
| 2024 Q1 | -3.02 Million USD | -83.66% |
| 2023 Q1 | -1.43 Million USD | -111.0% |
| 2023 Q2 | -1.53 Million USD | -6.87% |
| 2023 Q3 | -1.76 Million USD | -15.08% |
| 2023 FY | -6.52 Million USD | -49.51% |
| 2023 Q4 | -1.64 Million USD | 6.74% |
| 2022 Q4 | -681.64 Thousand USD | 54.54% |
| 2022 FY | -4.36 Million USD | -98.05% |
| 2022 Q1 | -955.13 Thousand USD | 4.77% |
| 2022 Q2 | -1.1 Million USD | -16.16% |
| 2022 Q3 | -1.49 Million USD | -35.15% |
| 2021 Q3 | -687.08 Thousand USD | -29.25% |
| 2021 Q4 | -1 Million USD | -45.98% |
| 2021 Q1 | -59.78 Thousand USD | 81.65% |
| 2021 Q2 | -531.58 Thousand USD | -789.19% |
| 2021 FY | -2.2 Million USD | -10.13% |
| 2020 Q3 | -257.11 Thousand USD | 69.82% |
| 2020 Q4 | -325.76 Thousand USD | -26.7% |
| 2020 FY | -2 Million USD | 45.13% |
| 2020 Q2 | -851.94 Thousand USD | -29.6% |
| 2020 Q1 | -657.37 Thousand USD | 37.79% |
| 2019 Q2 | -3.36 Million USD | -263.97% |
| 2019 Q3 | -1.4 Million USD | 58.22% |
| 2019 Q4 | -1.05 Million USD | 24.77% |
| 2019 FY | -3.64 Million USD | -15558.6% |
| 2019 Q1 | 2.05 Million USD | 173.16% |
| 2018 FY | 23.6 Thousand USD | 100.18% |
| 2018 Q4 | -2.8 Million USD | -358.06% |
| 2018 Q3 | 1.08 Million USD | 89.23% |
| 2018 Q2 | 573.92 Thousand USD | -50.79% |
| 2018 Q1 | 1.16 Million USD | 140.49% |
| 2017 Q3 | -3.5 Million USD | -8.38% |
| 2017 Q2 | -3.23 Million USD | -0.17% |
| 2017 Q1 | -3.23 Million USD | -14.86% |
| 2017 FY | -12.85 Million USD | 13.77% |
| 2017 Q4 | -2.88 Million USD | 17.92% |
| 2016 FY | -14.91 Million USD | -62.32% |
| 2016 Q2 | -4.09 Million USD | -0.01% |
| 2016 Q3 | -3.9 Million USD | 4.57% |
| 2016 Q4 | -2.81 Million USD | 27.99% |
| 2016 Q1 | -4.09 Million USD | -51.16% |
| 2015 Q2 | -1.2 Million USD | 41.91% |
| 2015 Q1 | -2.07 Million USD | 28.8% |
| 2015 Q4 | -2.7 Million USD | 15.44% |
| 2015 FY | -9.18 Million USD | -18.3% |
| 2015 Q3 | -3.2 Million USD | -166.27% |
| 2014 Q3 | -1.46 Million USD | 32.66% |
| 2014 Q4 | -2.9 Million USD | -99.03% |
| 2014 FY | -7.76 Million USD | 3.15% |
| 2014 Q1 | -1.22 Million USD | 66.94% |
| 2014 Q2 | -2.17 Million USD | -77.26% |
| 2013 Q2 | -1.34 Million USD | 40.28% |
| 2013 Q1 | -2.25 Million USD | -20.32% |
| 2013 Q4 | -3.7 Million USD | -417.08% |
| 2013 FY | -8.01 Million USD | 19.87% |
| 2013 Q3 | -716.26 Thousand USD | 46.78% |
| 2012 Q4 | -1.87 Million USD | 28.25% |
| 2012 Q1 | -2.75 Million USD | -13.91% |
| 2012 FY | -10 Million USD | -0.26% |
| 2012 Q2 | -2.77 Million USD | -0.72% |
| 2012 Q3 | -2.61 Million USD | 5.84% |
| 2011 FY | -9.98 Million USD | 40.91% |
| 2011 Q1 | -2.69 Million USD | 35.9% |
| 2011 Q3 | -2.43 Million USD | 0.24% |
| 2011 Q4 | -2.41 Million USD | 0.6% |
| 2011 Q2 | -2.43 Million USD | 9.66% |
| 2010 FY | -16.89 Million USD | -41.73% |
| 2010 Q4 | -4.2 Million USD | -23.75% |
| 2010 Q3 | -3.4 Million USD | 24.76% |
| 2010 Q2 | -4.51 Million USD | 3.47% |
| 2010 Q1 | -4.68 Million USD | -1388.91% |
| 2009 Q3 | -9.26 Million USD | -414.42% |
| 2009 FY | -11.91 Million USD | 57.02% |
| 2009 Q4 | 363.23 Thousand USD | 103.92% |
| 2009 Q1 | -1.21 Million USD | 70.63% |
| 2009 Q2 | -1.8 Million USD | -48.03% |
| 2008 Q2 | -4.92 Million USD | 54.4% |
| 2008 Q1 | -10.8 Million USD | -405.2% |
| 2008 FY | -27.73 Million USD | -230.97% |
| 2008 Q3 | -7.85 Million USD | -59.34% |
| 2008 Q4 | -4.14 Million USD | 47.24% |
| 2007 Q3 | -3.57 Million USD | -176.6% |
| 2007 Q2 | -1.29 Million USD | 6.27% |
| 2007 Q4 | -2.13 Million USD | 40.09% |
| 2007 FY | -8.37 Million USD | -296.32% |
| 2007 Q1 | -1.37 Million USD | -881.93% |
| 2006 FY | 4.26 Million USD | 354.86% |
| 2006 Q1 | 147.33 Thousand USD | -81.71% |
| 2006 Q2 | 1.53 Million USD | 938.9% |
| 2006 Q4 | 176.13 Thousand USD | -92.7% |
| 2006 Q3 | 2.41 Million USD | 57.68% |
| 2005 Q2 | -40.14 Thousand USD | 93.27% |
| 2005 FY | 938.25 Thousand USD | 121.9% |
| 2005 Q4 | 805.45 Thousand USD | 4.7% |
| 2005 Q3 | 769.26 Thousand USD | 2016.26% |
| 2005 Q1 | -596.31 Thousand USD | 28.6% |
| 2004 FY | -4.28 Million USD | -16.83% |
| 2004 Q4 | -835.17 Thousand USD | 39.17% |
| 2004 Q1 | -779.99 Thousand USD | 18.08% |
| 2004 Q2 | -1.29 Million USD | -66.15% |
| 2004 Q3 | -1.37 Million USD | -5.94% |
| 2003 Q2 | -893 Thousand USD | 14.16% |
| 2003 FY | -3.66 Million USD | 23.51% |
| 2003 Q4 | -952.08 Thousand USD | -21.87% |
| 2003 Q1 | -1.04 Million USD | 0.0% |
| 2003 Q3 | -781.25 Thousand USD | 12.51% |
| 2002 FY | -4.79 Million USD | 45.01% |
| 2001 FY | -8.71 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Cerus Corporation | -37.48 Million USD | 82.583% |
| OrthoPediatrics Corp. | -20.97 Million USD | 68.869% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | 44.943% |
| TELA Bio, Inc. | -46.66 Million USD | 86.007% |
| Spectral AI, Inc. | -20.85 Million USD | 68.69% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 89.256% |
| CVRx, Inc. | -41.19 Million USD | 84.151% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 1119.92% |
| Acutus Medical, Inc. | -81.66 Million USD | 92.004% |
| PetVivo Holdings, Inc. | -10.95 Million USD | 40.399% |
| Talis Biomedical Corporation | -62 Million USD | 89.47% |
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 89.403% |
| Bioventus Inc. | -156.23 Million USD | 95.821% |
| BrainsWay Ltd. | -4.19 Million USD | -55.575% |
| Envoy Medical, Inc. | -29.9 Million USD | 78.168% |
| electroCore, Inc. | -18.83 Million USD | 65.331% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | 26.22% |
| IceCure Medical Ltd | -14.65 Million USD | 55.436% |
| Inogen, Inc. | -102.44 Million USD | 93.627% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 87.602% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | 52.496% |
| MaxCyte, Inc. | -37.92 Million USD | 82.782% |
| Nexalin Technology, Inc. | -4.64 Million USD | -40.458% |
| Orthofix Medical Inc. | -151.39 Million USD | 95.687% |
| PAVmed Inc | -64.17 Million USD | 89.825% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 87.555% |
| RxSight, Inc. | -48.6 Million USD | 86.567% |
| Sight Sciences, Inc. | -55.54 Million USD | 88.245% |
| SI-BONE, Inc. | -43.33 Million USD | 84.933% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 86.816% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | 51.929% |
| Venus Concept Inc. | -37.25 Million USD | 82.471% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 88.94% |
| LivaNova PLC | 17.54 Million USD | 137.214% |
| 908 Devices Inc. | -36.39 Million USD | 82.061% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 96.502% |
| Nemaura Medical Inc. | -14.14 Million USD | 53.835% |
| NeuroPace, Inc. | -32.95 Million USD | 80.187% |
| LENSAR, Inc. | -14.38 Million USD | 54.603% |
| Apyx Medical Corporation | -18.71 Million USD | 65.107% |
| Cutera, Inc. | -162.83 Million USD | 95.99% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | 39.709% |
| BioSig Technologies, Inc. | -29.04 Million USD | 77.516% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 92.101% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | 70.44% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 109.639% |
| Axonics, Inc. | -6.08 Million USD | -7.252% |
| Outset Medical, Inc. | -172.79 Million USD | 96.221% |
| IRIDEX Corporation | -9.57 Million USD | 31.771% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 93.834% |
| IRadimed Corporation | 17.19 Million USD | 137.978% |
| Tivic Health Systems, Inc. | -8.24 Million USD | 20.797% |
| INVO Bioscience, Inc. | -8.03 Million USD | 18.733% |
| Telesis Bio, Inc. | -47.72 Million USD | 86.318% |
| Viemed Healthcare, Inc. | 10.24 Million USD | 163.746% |
| Varex Imaging Corporation | -47.7 Million USD | 86.311% |
| Quipt Home Medical Corp. | -2.78 Million USD | -134.536% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 42.145% |
| Pulmonx Corporation | -60.84 Million USD | 89.268% |
| Dynatronics Corporation | -2.69 Million USD | -142.037% |
| Modular Medical, Inc. | -17.47 Million USD | 62.625% |
| ReShape Lifesciences Inc. | -11.38 Million USD | 42.658% |
| Semler Scientific, Inc. | 20.58 Million USD | 131.723% |
| InMode Ltd. | 197.91 Million USD | 103.299% |
| Bruker Corporation | 427.2 Million USD | 101.528% |
| Cytosorbents Corporation | -28.5 Million USD | 77.095% |
| DexCom, Inc. | 541.5 Million USD | 101.206% |
| Align Technology, Inc. | 445.05 Million USD | 101.467% |
| Viveve Medical, Inc. | -22.02 Million USD | 70.357% |
| ZimVie Inc. | -393.28 Million USD | 98.34% |
| Movano Inc. | -29.28 Million USD | 77.702% |
| Cytek Biosciences, Inc. | -12.14 Million USD | 46.251% |
| Nexalin Technology, Inc. | -4.64 Million USD | -40.458% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 1119.92% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 97.067% |
| Profound Medical Corp. | -28.56 Million USD | 77.145% |
| Insulet Corporation | 206.3 Million USD | 103.165% |
| enVVeno Medical Corporation | -23.51 Million USD | 72.234% |
| Surmodics, Inc. | -11.54 Million USD | 43.428% |
| iCAD, Inc. | -4.84 Million USD | -34.712% |
| Nuwellis, Inc. | -20.2 Million USD | 67.69% |
| Biotricity, Inc. | -14.09 Million USD | 53.673% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 94.709% |
| Aethlon Medical, Inc. | -12.2 Million USD | 46.515% |
| InspireMD, Inc. | -19.91 Million USD | 67.215% |
| PAVmed Inc. | -64.17 Million USD | 89.825% |
| BIOLASE, Inc. | -20.63 Million USD | 68.353% |
| Beyond Air, Inc. | -60.24 Million USD | 89.161% |
| FONAR Corporation | 10.56 Million USD | 161.789% |
| AxoGen, Inc. | -21.71 Million USD | 69.932% |
| Vivani Medical, Inc. | -25.65 Million USD | 74.546% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 122.898% |
| Inari Medical, Inc. | -1.63 Million USD | -299.113% |
| UFP Technologies, Inc. | 44.92 Million USD | 114.535% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | -27.223% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | 1.146% |
| Tenon Medical, Inc. | -15.58 Million USD | 58.093% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | 57.672% |
| Co-Diagnostics, Inc. | -35.33 Million USD | 81.52% |
| AdaptHealth Corp. | -678.89 Million USD | 99.038% |
| Sintx Technologies, Inc. | -8.25 Million USD | 20.941% |
| NanoVibronix, Inc. | -3.71 Million USD | -75.95% |
| Quanterix Corporation | -32.33 Million USD | 79.806% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 42.145% |
| Sensus Healthcare, Inc. | 485 Thousand USD | 1446.286% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 97.871% |
| TransMedics Group, Inc. | -25.02 Million USD | 73.911% |
| ReWalk Robotics Ltd. | -22.13 Million USD | 70.499% |
| Hyperfine, Inc. | -44.23 Million USD | 85.24% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 91.682% |
| Biomerica, Inc. | -5.97 Million USD | -9.225% |
| Bone Biologics Corporation | -8.94 Million USD | 27.034% |
| AVITA Medical, Inc. | -39.16 Million USD | 83.33% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | 34.403% |
| Silk Road Medical, Inc | -55.74 Million USD | 88.286% |